Fraud Breeds Retractions

An analysis of retractions dating back to 1977 shows that most papers are retracted due to misconduct.

Written bySabrina Richards
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientific misconduct contributes to more retractions than previously realized, according to a new analysis published today (October 1) in Proceedings of the National Academy of Sciences. Using retractions indexed in Pubmed, researchers found that fabrication, falsification, and duplication led to more retractions than error or plagiarism.

“Tracking down these corrections and retractions to find out what is going on is really innovative,” said David Resnik, a bioethicist at the National Institute of Environmental Health Sciences, who did not participate in the research. It turns out that “a high percentage of time, there really some kind of misconduct” behind retractions.

Previous studies suggested that error, not ethical lapses, prompted most retractions. In order to get a clearer sense of what mistakes led to scientific studies being pulled from the literature, lead author Arturo Casadevall at Albert Einstein College of Medicine and his colleagues identified more than 2,000 articles listed in Pubmed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies